11.1. Clinical data and baseline assessment
Traumatic brain injury, TBI, Coma, blindness
COMA, BLINDNESS
Between January 2019 and December 2022, a comprehensive assessment was conducted on 392 individuals with severe TBI. Out of these, 304 patients were initially included and randomly assigned to receive either RIPC treatment (n = 153) or a control treatment (n = 151). No instances of visible blindness were observed during the duration of the study. Moreover, there were no statistically significant disparities found in the baseline information between the 2 groups (Table Comparison of baseline data.BMI = body mass index, CT = computerized tomography, Glasgow Coma Scale, SD = standard deviation, TBI = Traumatic brain injury.Trial profile.